Phio Pharmaceuticals Corp. · NASDAQ:PHIO
Deming David H bought 12,000 Phio Pharmaceuticals Corp. shares (Form 4)
Traded Nov 10 to Nov 11, 2026 · Filed Nov 12, 2026
From Nov 10 to Nov 11, 2026, Deming David H (Director) bought 12,000 Phio Pharmaceuticals Corp. shares at an average US$0.84 for US$10,066, leaving 49,800 shares. Filed Nov 12, 2026 (Form 4).
- Bought
- 12,000 shares
- Price
- US$0.84 average (US$0.84 to US$0.84)
- Value
- US$10,066
- Holding after
- 49,800 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 10, 2026 | Common Stock, $.0001 par value | Buy | 6,800 | US$0.84 | 44,600 | Direct |
| Nov 11, 2026 | Common Stock, $.0001 par value | Buy | 5,200 | US$0.84 | 49,800 | Direct |
Source
Download original · View original at SEC
Related
- Phio Pharmaceuticals Corp.
- Deming David H
- Phio Pharmaceuticals Corp. shareholders
- Form 4 · Deming David H · Nov 16, 2026
- Schedule 13G/A · CVI Investments, Inc. · Nov 16, 2026
- Form 4 · Plott Ronald Todd · Nov 10, 2026
- Form 4 · Bitterman Robert J · Nov 10, 2026
- Form 4 · Plott Ronald Todd · Sep 30, 2026
- Form 4 · Bitterman Robert J · Sep 29, 2026